deferiprone has been researched along with Infectious Diseases in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Modell, B | 1 |
| Khan, M | 1 |
| Darlison, M | 1 |
| Westwood, MA | 1 |
| Ingram, D | 1 |
| Pennell, DJ | 1 |
1 other study available for deferiprone and Infectious Diseases
| Article | Year |
|---|---|
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.
Topics: Adolescent; Adult; Anemia; beta-Thalassemia; Bone Marrow Transplantation; Cardiomyopathies; Cause of | 2008 |